Preface by the Editors.- Foreword by the VAS Board.- Foreword by the UEMS General Secretary.-Part 1 : Pathophysiology.- 1. Arterial and Venous Haemodynamics.- 2. Introduction to Endothelial Cell Pathophysiology and Angiogenesis.- 3. Pathogenesis of Atherosclerosis Key Points.- 4. Pathophysiology of Arterial and Venous Thrombosis.- 5. Arterial Stiffness.- 6. Haemorheological Aspects of Peripheral Vascular Diseases.- 7. Physiology and Pathophysiology of the Lymphatic System.- 8. Microcirculation.- Part 2: Patient evaluation - Clinical Evaluation.- 9. Medical History in Vascular Diseases.- 10. The Physical Examination.- Part 3: Patient evaluation - Diagnostics.- 11. Markers of Preclinical Atherosclerosis and their Clinical Relevance.- 12. Continuous Wave Doppler Ultrasound.- 13. Duplex Ultrasound for the Diagnosis of Vascular Diseases.- 14. Angiography, CT and MR Angiography.- 15. Other Complementary Techniques.- 16. Capillaroscopy.- 17. Laser Doppler Fluxmetry.- 18. Transcutaneous PO2 Measurement.- Part 4: Arterial diseases - Introduction to Arterial diseases: how to manage main Risk factors.- 19. Stop Smoking.- 20. Management and therapy of Arterial Hypertension.- 21. Management and therapy of Diabetes.- 22. Management and therapy of Dyslipidemia.- 23. How to Evaluate and Reduce Micro- and/or Macrovascular Residual Risk?.- 24. Multisite Artery Disease.- Part 5: Arterial diseases - Peripheral Arterial Disease.- 25. Incidence and Prevalence of Peripheral Arterial Disease.- 26. An Epidemiological Perspective.-27. Asymptomatic and Intermittent Claudication- Overview and medical therapy.- 28. Critical Limb Ischaemia- Overview and medical therapy.- 29. Acute Limb Ischaemia.- 30. Primary Care of Peripheral Arterial Disease.- 31. Peripheral Arterial Disease Rehabilitation.- 32. IVUS guided PAD treatment.- 33. Vascular amputation.- Part 6: Arterial diseases - Diabetes and Arterial Disease.- 34. Epidemiology of Diabetes.- 35. Prediabetes, Diabetes & Peripheral Arterial Disease.- 36. The Diabetic Foot.- Part 7: Thromboangiitis Obliterans.- 37. Thromboangiitis Obliterans.- Part 8: Fibromuscular Dysplasia.- 38. Fibromuscular Dysplasia.- Part 9: Cerebrovascular Disease.- 39. Epidemiology of Cerebrovascular Disease.- 40. Stroke, Transient Ischaemic Attack, and Minor Stroke.- 41. Secondary Prevention after Ischaemic Stroke and Transient Ischaemic Attack.- 42. Indications for Carotid Surgery.- 43. Indication for Endovascular therapy.- 44. Subclavian Steal Syndrome.- Part 10: Aortic and Visceral Arterial Disease.- 45. Medical Aspects on Abdominal Aortic Aneurysm.- 46. Aortic Dissection.- 47. Mesenteric Vascular Disease.- 48. Renal Vascular Disease.- 49. Mesenteric and renal endovascular therapy.- 50. Dialysis Vascular Access for Angiologists.- Part 11: Venous Diseases: Chronic Venous Insufficiency.- 51. Epidemiology of Chronic Venous Disease of Lower Limbs.- 52. Epidemiology of Venous Leg Ulceration.- 53. CEAP Classification of Chronic Venous Disease.- 54. Varicose Veins.- 55. Prevention and management of VenousUlcers.- 56. Management of Chronic Venous Disease.- 57. Compression Therapy.- 58. Deep Venous Valve Reconstruction. Indications and Results.- Part 12: Pelvic Venous Congestive Syndrom Editor.- 59. Overview.- 60. Therapy.- Part 13: Venous Thromboembolism.- 61. Epidemiology of Venous Thromboembolism.- 62. Deep Venous Thrombosis.- 63. Pulmonary Embolism.- 64. Management of Venous Thromboembolic Disease.- 65. Venous Thromboembolism in Pregnancy.- 66. Cancer-associated thrombosis.- 67. Thrombophylia.- 68. Isolated Distal Deep Vein Thrombosis.- 69. Post-thrombotic Syndrome.- 70. Endovascular treatment for chronic venous obstructions.- 71. Peculiar aspect of thrombogenesis in COVID19.- Part 14: Lymphatic Diseases (in collaboration with ESL) - Anatomy of the Lymphatic System on Human Specimen.- 72. General Anatomy of the Lymphatic System.- 73. The Drainage of the Front of the Head. 25 Human Specimens.- Part 15: Lymphatic Diseases (in collaboration with ESL) - Aetiology, Staging and Diagnosis Lymphoedema.- 74. Aetiology, Staging and Diagnosis of Lymphedema.- Part 16: Lymphatic Diseases (in collaboration with ESL) - Diagnosis of Lymphoedema.- 75. Current Clinical and Genetic Assessment of Primary Lymphoedema.- 76. Instrumental Diagnosis of Lymphoedema and Lymphatic Diseases.- 77. Near-Infrared Fluorescence Lymphatic Imaging.- 78. From Conventional Planar Lymphoscintigraphy to Hybrid Imaging Lymphoscintigraphy to Assess the Lymphatic System.- Part 17: Lymphatic Diseases (in collaboration with ESL) - Conservative Treatment of Lymphoedema.- 79. Conservative Therapy of Lymphoedema.- 80. Prescribing Compression in the Management of Lymphoedema.- 81. Physical Treatment of Oedema of the Upper Limb The Derivative Pathways.- Part 18: Lymphatic Diseases (in collaboration with ESL) - Surgical Treatment of Lymphoedema.- 82. Surgical Therapy of Lymphoedema: Pathophysiologic bases and Clinical Outcome.- 83. Multiple lymphatic-venous anastomoses associated to selected lymphatic-sparing liposuction for the surgical treatment of lymphoedema.- Part 19: Lymphatic Diseases (in collaboration with ESL) - Prevention of Lymphoedema.- 84. Non-Surgical Prevention of Arm Lymphoedema Following Breast Cancer Treatment.- 85. LY.M.P.H.A. Technique for Prevention of Secondary Lymphoedema Following Oncologic Surgery.- Part 20: Lymphatic Diseases (in collaboration with ESL) - Lymphoedema in Paediatrics.- 86. Lymphoedema in Paediatrics.- 87. Neonatal and Paediatric Lymphoedema.- Part 21: Lymphatic Diseases (in collaboration with ESL) - Lipedema.- 88. Diagnosis and treatment of Lipedema.- Part 22: Vasospastic Disorder and Vasculitis.- 89. Raynaud-Related Diseases.- 90. Large Vessel Vasculitis.- Part 23: Vascular Malformations.- 91. Epidemiology of Vascular Anomalies.- 92. Classification of Vascular Anomalies.- 93. Vascular Malformations-Genetics.- Part 24: Miscellaneous.- 94. ThoracicOutlet Syndrome.- 95. Vascular Diseases Related To Drugs.- Part 25: Ethics and Equity in Vascular disease.- 96. Social Determinants.- 97. Ethical counselling in the multicultural era.- 98. Comorbidity, Multimorbidity, and the Challenge of Equity (Previously in.Arterial disease).- 99. Independence of Research.- Part 26: Advanced Research in therapy for Vascular Diseases.- 100. Advanced Research in therapy for Vascular Diseases.